<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35741724</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Multisystem Proteinopathy Due to <i>VCP</i> Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">963</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13060963</ELocationID><Abstract><AbstractText>In this work, we review clinical features and genetic diagnosis of diseases caused by mutations in the gene encoding valosin-containing protein (VCP/p97), the functionally diverse AAA-ATPase. VCP is crucial to a multitude of cellular functions including protein quality control, stress granule formation and clearance, and genomic integrity functions, among others. Pathogenic mutations in <i>VCP</i> cause multisystem proteinopathy (VCP-MSP), an autosomal dominant, adult-onset disorder causing dysfunction in several tissue types. It can result in complex neurodegenerative conditions including inclusion body myopathy, frontotemporal dementia, amyotrophic lateral sclerosis, or combinations of these. There is also an association with other neurodegenerative phenotypes such as Alzheimer-type dementia and Parkinsonism. Non-neurological presentations include Paget disease of bone and may also include cardiac dysfunction. We provide a detailed discussion of genotype-phenotype correlations, recommendations for genetic diagnosis, and genetic counselling implications of VCP-MSP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pfeffer</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7657-7098</Identifier><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alberta Child Health Research Institute, Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Grace</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0557-5482</Identifier><AffiliationInfo><Affiliation>Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California Irvine Medical Center, Orange, CA 92868, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontifex</LastName><ForeName>Carly S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fanganiello</LastName><ForeName>Roberto D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-5355-255X</Identifier><AffiliationInfo><Affiliation>Oral Ecology Research Group, Faculty of Dental Medicine, Universit&#xe9; Laval, Quebec City, QC G1V 0A6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peck</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cure VCP Disease, Inc., Americus, GA 31709, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weihl</LastName><ForeName>Conrad C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimonis</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California Irvine Medical Center, Orange, CA 92868, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001414</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="C000614178">VCP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="D000074405">Valosin Containing Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010001" MajorTopicYN="Y">Osteitis Deformans</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074405" MajorTopicYN="Y">Valosin Containing Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VCP</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">genotype-phenotype correlation</Keyword><Keyword MajorTopicYN="N">multisystem proteinopathy</Keyword><Keyword MajorTopicYN="N">myopathy</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35741724</ArticleId><ArticleId IdType="pmc">PMC9222868</ArticleId><ArticleId IdType="doi">10.3390/genes13060963</ArticleId><ArticleId IdType="pii">genes13060963</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dalal S., Hanson P.I. Membrane traffic: What drives the AAA motor? Cell. 2001;104:5&#x2013;8. doi: 10.1016/S0092-8674(01)00186-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00186-6</ArticleId><ArticleId IdType="pubmed">11163235</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H., Weihl C.C. The VCP/p97 system at a glance: Connecting cellular function to disease pathogenesis. J. Cell Sci. 2014;127:3877&#x2013;3883. doi: 10.1242/jcs.093831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.093831</ArticleId><ArticleId IdType="pmc">PMC4163641</ArticleId><ArticleId IdType="pubmed">25146396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich E., Kerem A., Frohlich K.U., Diamant N., Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 2002;22:626&#x2013;634. doi: 10.1128/MCB.22.2.626-634.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.2.626-634.2002</ArticleId><ArticleId IdType="pmc">PMC139744</ArticleId><ArticleId IdType="pubmed">11756557</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih Y.T., Hsueh Y.P. VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation. Nat. Commun. 2016;7:11020. doi: 10.1038/ncomms11020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11020</ArticleId><ArticleId IdType="pmc">PMC4800434</ArticleId><ArticleId IdType="pubmed">26984393</ArticleId></ArticleIdList></Reference><Reference><Citation>Rape M., Hoppe T., Gorr I., Kalocay M., Richly H., Jentsch S. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell. 2001;107:667&#x2013;677. doi: 10.1016/S0092-8674(01)00595-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00595-5</ArticleId><ArticleId IdType="pubmed">11733065</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchiyama K., Kondo H. p97/p47-Mediated biogenesis of Golgi and ER. J. Biochem. 2005;137:115&#x2013;119. doi: 10.1093/jb/mvi028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvi028</ArticleId><ArticleId IdType="pubmed">15749824</ArticleId></ArticleIdList></Reference><Reference><Citation>Frohlich K.U., Fries H.W., Rudiger M., Erdmann R., Botstein D., Mecke D. Yeast cell cycle protein CDC48p shows full-length homology to the mammalian protein VCP and is a member of a protein family involved in secretion, peroxisome formation, and gene expression. J. Cell Biol. 1991;114:443&#x2013;453. doi: 10.1083/jcb.114.3.443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.114.3.443</ArticleId><ArticleId IdType="pmc">PMC2289087</ArticleId><ArticleId IdType="pubmed">1860879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009;187:875&#x2013;888. doi: 10.1083/jcb.200908115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908115</ArticleId><ArticleId IdType="pmc">PMC2806317</ArticleId><ArticleId IdType="pubmed">20008565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari V., Cristofani R., Tedesco B., Crippa V., Chierichetti M., Casarotto E., Cozzi M., Mina F., Piccolella M., Galbiati M., et al. Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy. Int. J. Mol. Sci. 2022;23:1939. doi: 10.3390/ijms23041939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23041939</ArticleId><ArticleId IdType="pmc">PMC8878954</ArticleId><ArticleId IdType="pubmed">35216053</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004;36:377&#x2013;381. doi: 10.1038/ng1332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1332</ArticleId><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Korb M.K., Kimonis V.E., Mozaffar T. Multisystem proteinopathy: Where myopathy and motor neuron disease converge. Muscle Nerve. 2021;63:442&#x2013;454. doi: 10.1002/mus.27097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27097</ArticleId><ArticleId IdType="pubmed">33145792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimonis V.E., Mehta S.G., Fulchiero E.C., Thomasova D., Pasquali M., Boycott K., Neilan E.G., Kartashov A., Forman M.S., Tucker S., et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am. J. Med. Genet. A. 2008;146:745&#x2013;757. doi: 10.1002/ajmg.a.31862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.31862</ArticleId><ArticleId IdType="pmc">PMC2467391</ArticleId><ArticleId IdType="pubmed">18260132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimonis V.E., Fulchiero E., Vesa J., Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: Review of a unique disorder. Biochim. Biophys. Acta. 2008;1782:744&#x2013;748. doi: 10.1016/j.bbadis.2008.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2008.09.003</ArticleId><ArticleId IdType="pubmed">18845250</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P. Multisystem proteinopathy: Intersecting genetics in muscle, bone, and brain degeneration. Neurology. 2015;85:658&#x2013;660. doi: 10.1212/WNL.0000000000001862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001862</ArticleId><ArticleId IdType="pubmed">26208960</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I., Van Bortel I., Nicolas G., Bouya-Ahmed K., Camuzat A., Wallon D., De Septenville A., Latouche M., Lattante S., Kabashi E., et al. hnRNPA2B1 and hnRNPA1 mutations are rare in patients with &#x201c;multisystem proteinopathy&#x201d; and frontotemporal lobar degeneration phenotypes. Neurobiol. Aging. 2014;35:934.e5&#x2013;934.e6. doi: 10.1016/j.neurobiolaging.2013.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.016</ArticleId><ArticleId IdType="pubmed">24119545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Shi S.L. The roles of hnRNP A2/B1 in RNA biology and disease. Wiley Interdiscip. Rev. RNA. 2021;12:e1612. doi: 10.1002/wrna.1612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1612</ArticleId><ArticleId IdType="pubmed">32588964</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke J.P., Thibault P.A., Salapa H.E., Levin M.C. A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative Disease. Front. Mol. Biosci. 2021;8:659610. doi: 10.3389/fmolb.2021.659610.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.659610</ArticleId><ArticleId IdType="pmc">PMC8072284</ArticleId><ArticleId IdType="pubmed">33912591</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Shu S., Wang R.R., Liu F., Cui B., Guo X.N., Lu C.X., Li X.G., Liu M.S., Peng B., et al. Whole-exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS. Neurology. 2016;87:1763&#x2013;1769. doi: 10.1212/WNL.0000000000003256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003256</ArticleId><ArticleId IdType="pubmed">27694260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A.V., Mills J., Lapierre L.R. Selective Autophagy Receptor p62/SQSTM1, a Pivotal Player in Stress and Aging. Front. Cell Dev. Biol. 2022;10:793328. doi: 10.3389/fcell.2022.793328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.793328</ArticleId><ArticleId IdType="pmc">PMC8883344</ArticleId><ArticleId IdType="pubmed">35237597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucelli R.C., Arhzaouy K., Pestronk A., Pittman S.K., Rojas L., Sue C.M., Evila A., Hackman P., Udd B., Harms M.B., et al. SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles. Neurology. 2015;85:665&#x2013;674. doi: 10.1212/WNL.0000000000001864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001864</ArticleId><ArticleId IdType="pmc">PMC4553032</ArticleId><ArticleId IdType="pubmed">26208961</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea S.L., Majcher V., Searle M.S., Layfield R. SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD. Exp. Cell Res. 2014;325:27&#x2013;37. doi: 10.1016/j.yexcr.2014.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2014.01.020</ArticleId><ArticleId IdType="pubmed">24486447</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Jonson P.H., Sarparanta J., Palmio J., Sarkar M., Vihola A., Evila A., Suominen T., Penttila S., Savarese M., et al. TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations. J. Clin. Investig. 2018;128:1164&#x2013;1177. doi: 10.1172/JCI97103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI97103</ArticleId><ArticleId IdType="pmc">PMC5824866</ArticleId><ArticleId IdType="pubmed">29457785</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Z., Pontifex C.S., Berini S., Hamilton L.E., Naddaf E., Wieben E., Aleff R.A., Martens K., Gruber A., Engel A.G., et al. Myopathy With SQSTM1 and TIA1 Variants: Clinical and Pathological Features. Front. Neurol. 2018;9:147. doi: 10.3389/fneur.2018.00147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00147</ArticleId><ArticleId IdType="pmc">PMC5868303</ArticleId><ArticleId IdType="pubmed">29599744</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilks N., Kedersha N., Ayodele M., Shen L., Stoecklin G., Dember L.M., Anderson P. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol. Biol. Cell. 2004;15:5383&#x2013;5398. doi: 10.1091/mbc.e04-08-0715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-08-0715</ArticleId><ArticleId IdType="pmc">PMC532018</ArticleId><ArticleId IdType="pubmed">15371533</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik A.M., Barmada S.J. Matrin 3 in neuromuscular disease: Physiology and pathophysiology. JCI Insight. 2021;6:e143948. doi: 10.1172/jci.insight.143948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143948</ArticleId><ArticleId IdType="pmc">PMC7821588</ArticleId><ArticleId IdType="pubmed">33427209</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Pioro E.P., Boehringer A., Chia R., Feit H., Renton A.E., Pliner H.A., Abramzon Y., Marangi G., Winborn B.J., et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 2014;17:664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K.P., Tsai P.C., Liao Y.C., Chen W.T., Tsai C.P., Soong B.W., Lee Y.C. Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:2005.e1&#x2013;2005.e4. doi: 10.1016/j.neurobiolaging.2015.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.008</ArticleId><ArticleId IdType="pubmed">25771394</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond C.S., Gan-Or Z., Spiegelman D., Laurent S.B., Szuto A., Hodgkinson A., Dionne-Laporte A., Provencher P., de Carvalho M., Orru S., et al. Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2016;37:209.e17&#x2013;209.e21. doi: 10.1016/j.neurobiolaging.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.09.013</ArticleId><ArticleId IdType="pubmed">26493020</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., De Septenville A., Teyssou E., Daniau M., Camuzat A., Albert M., LeGuern E., Galimberti D., French research network on F.T.D., Ftd A.L.S., et al. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients. Neurobiol. Aging. 2014;35:2882.e13&#x2013;2882.e15. doi: 10.1016/j.neurobiolaging.2014.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.016</ArticleId><ArticleId IdType="pubmed">25158920</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro M., Venkateswaran N., Peters S.T., Deyle D.R., Bower M., Koob M.D., Boeve B.F., Vossel K. Case Report: Early-Onset Behavioral Variant Frontotemporal Dementia in Patient With Retrotransposed Full-Length Transcript of Matrin-3 Variant 5. Front. Neurol. 2020;11:600468. doi: 10.3389/fneur.2020.600468.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.600468</ArticleId><ArticleId IdType="pmc">PMC7779795</ArticleId><ArticleId IdType="pubmed">33408686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackman P., Sarparanta J., Lehtinen S., Vihola A., Evila A., Jonson P.H., Luque H., Kere J., Screen M., Chinnery P.F., et al. Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Ann. Neurol. 2013;73:500&#x2013;509. doi: 10.1002/ana.23831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23831</ArticleId><ArticleId IdType="pubmed">23401021</ArticleId></ArticleIdList></Reference><Reference><Citation>Klar J., Sobol M., Melberg A., Mabert K., Ameur A., Johansson A.C., Feuk L., Entesarian M., Orlen H., Casar-Borota O., et al. Welander distal myopathy caused by an ancient founder mutation in TIA1 associated with perturbed splicing. Hum. Mutat. 2013;34:572&#x2013;577. doi: 10.1002/humu.22282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22282</ArticleId><ArticleId IdType="pubmed">23348830</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C., Annu K., Baker M., Perkerson R.B., Kurti A., et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 2017;95:808&#x2013;816.e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek R.A., van Rheenen W., Pulit S.L., Kenna K.P., Ticozzi N., Kooyman M., McLaughlin R.L., Moisse M., van Eijk K.R., van Vugt J., et al. Reconsidering the causality of TIA1 mutations in ALS. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2018;19:1&#x2013;3. doi: 10.1080/21678421.2017.1413118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1413118</ArticleId><ArticleId IdType="pmc">PMC6516059</ArticleId><ArticleId IdType="pubmed">29235362</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran-Heravi Y., Dillen L., Nguyen H.P., Van Mossevelde S., Baets J., De Jonghe P., Engelborghs S., De Deyn P.P., Vandenbulcke M., Vandenberghe R., et al. No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients. Neurobiol. Aging. 2018;69:293.e9&#x2013;293.e11. doi: 10.1016/j.neurobiolaging.2018.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.05.005</ArticleId><ArticleId IdType="pubmed">29886022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan T.A., Tumbarello D.A. Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy. Front. Immunol. 2018;9:1024. doi: 10.3389/fimmu.2018.01024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01024</ArticleId><ArticleId IdType="pmc">PMC5962687</ArticleId><ArticleId IdType="pubmed">29867991</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Albagha O.M., Visconti M.R., Alonso N., Langston A.L., Cundy T., Dargie R., Dunlop M.G., Fraser W.D., Hooper M.J., Isaia G., et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget&#x2019;s disease of bone. Nat. Genet. 2010;42:520&#x2013;524. doi: 10.1038/ng.562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.562</ArticleId><ArticleId IdType="pmc">PMC3217192</ArticleId><ArticleId IdType="pubmed">20436471</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Bieniek K.F., Finch N., van de Vorst M., Baker M., Perkersen R., Brown P., Ravenscroft T., van Blitterswijk M., Nicholson A.M., et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 2015;130:77&#x2013;92. doi: 10.1007/s00401-015-1436-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1436-x</ArticleId><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Obeidi E., Al-Tahan S., Surampalli A., Goyal N., Wang A.K., Hermann A., Omizo M., Smith C., Mozaffar T., Kimonis V. Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy. Clin. Genet. 2018;93:119&#x2013;125. doi: 10.1111/cge.13095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13095</ArticleId><ArticleId IdType="pmc">PMC5739971</ArticleId><ArticleId IdType="pubmed">28692196</ArticleId></ArticleIdList></Reference><Reference><Citation>Farpour F., Tehranzadeh J., Donkervoort S., Smith C., Martin B., Vanjara P., Osann K., Kimonis V.E. Radiological features of Paget disease of bone associated with VCP myopathy. Skeletal. Radiol. 2012;41:329&#x2013;337. doi: 10.1007/s00256-011-1193-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00256-011-1193-4</ArticleId><ArticleId IdType="pubmed">21643886</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez M.A., Feely S.M., Speziani F., Strickland A.V., Danzi M., Bacon C., Lee Y., Chou T.F., Blanton S.H., Weihl C.C., et al. A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. Brain. 2014;137:2897&#x2013;2902. doi: 10.1093/brain/awu224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu224</ArticleId><ArticleId IdType="pmc">PMC4208462</ArticleId><ArticleId IdType="pubmed">25125609</ArticleId></ArticleIdList></Reference><Reference><Citation>Gite J., Milko E., Brady L., Baker S.K. Phenotypic convergence in Charcot-Marie-Tooth 2Y with novel VCP mutation. Neuromuscul. Disord. 2020;30:232&#x2013;235. doi: 10.1016/j.nmd.2020.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2020.02.002</ArticleId><ArticleId IdType="pubmed">32165109</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Warrenburg B.P., Schouten M.I., de Bot S.T., Vermeer S., Meijer R., Pennings M., Gilissen C., Willemsen M.A., Scheffer H., Kamsteeg E.J. Clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene-disease associations and unanticipated rare disorders. Eur. J. Hum. Genet. 2017;25:393. doi: 10.1038/ejhg.2016.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2016.168</ArticleId><ArticleId IdType="pmc">PMC5315505</ArticleId><ArticleId IdType="pubmed">28179632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimonis V.E., Watts G.D. Autosomal dominant inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Alzheimer Dis. Assoc. Disord. 2005;19((Suppl. S1)):S44&#x2013;S47. doi: 10.1097/01.wad.0000183081.76820.5a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wad.0000183081.76820.5a</ArticleId><ArticleId IdType="pubmed">16317258</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.D., Jackson A.P., Barresi R., Smart C.M., Eugenicos M., Summers D., Clegg S., Straub V., Stone J. Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): Clinical features including sphincter disturbance in a large pedigree. J. Neurol. Neurosurg. Psychiatry. 2009;80:583&#x2013;584. doi: 10.1136/jnnp.2008.148676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.148676</ArticleId><ArticleId IdType="pubmed">19372299</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G., Povitz M. Respiratory management of patients with neuromuscular disease: Current perspectives. Degener Neurol Neuromuscul. Dis. 2016;6:111&#x2013;118. doi: 10.2147/DNND.S87323.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DNND.S87323</ArticleId><ArticleId IdType="pmc">PMC6053085</ArticleId><ArticleId IdType="pubmed">30050373</ArticleId></ArticleIdList></Reference><Reference><Citation>Korb M., Peck A., Alfano L.N., Berger K.I., James M.K., Ghoshal N., Healzer E., Henchcliffe C., Khan S., Mammen P.P.A., et al. Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy. Orphanet J. Rare Dis. 2022;17:23. doi: 10.1186/s13023-022-02172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02172-5</ArticleId><ArticleId IdType="pmc">PMC8800193</ArticleId><ArticleId IdType="pubmed">35093159</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerath N.U., Crockett C.D., Moore S.A., Shy M.E., Weihl C.C., Chou T.F., Grider T., Gonzalez M.A., Zuchner S., Swenson A. Rare Manifestation of a c.290 C&gt;T, p.Gly97Glu VCP Mutation. Case Rep. Genet. 2015;2015:239167. doi: 10.1155/2015/239167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/239167</ArticleId><ArticleId IdType="pmc">PMC4386706</ArticleId><ArticleId IdType="pubmed">25878907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno F., Conidi M.E., Puccio G., Frangipane F., Lagana V., Bernardi L., Smirne N., Mirabelli M., Colao R., Curcio S., et al. A Novel Mutation (D395A) in Valosin-Containing Protein Gene Is Associated With Early Onset Frontotemporal Dementia in an Italian Family. Front. Genet. 2021;12:795029. doi: 10.3389/fgene.2021.795029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.795029</ArticleId><ArticleId IdType="pmc">PMC8669739</ArticleId><ArticleId IdType="pubmed">34917136</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwich N.F., Phan J.M., Kim B., Suh E., Papatriantafyllou J.D., Changolkar L., Nguyen A.T., O&#x2019;Rourke C.M., He Z., Porta S., et al. Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science. 2020;370:eaay8826. doi: 10.1126/science.aay8826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay8826</ArticleId><ArticleId IdType="pmc">PMC7818661</ArticleId><ArticleId IdType="pubmed">33004675</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinke P., Kerr A.R.W., Czapiewski R., de Las Heras J.I., Dixon C.R., Harris E., Kolbel H., Muntoni F., Schara U., Straub V., et al. A multistage sequencing strategy pinpoints novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as its pathomechanism. EBioMedicine. 2019;53:102587. doi: 10.1016/j.ebiom.2019.11.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.048</ArticleId><ArticleId IdType="pmc">PMC7000448</ArticleId><ArticleId IdType="pubmed">31862442</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E., Traynor B.J., Chio A., Restagno G., Mandrioli J., Benatar M., Taylor J.P., Singleton A.B. Mutational analysis of the VCP gene in Parkinson&#x2019;s disease. Neurobiol. Aging. 2012;33:209.e1&#x2013;209.e2. doi: 10.1016/j.neurobiolaging.2011.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.07.011</ArticleId><ArticleId IdType="pmc">PMC3221929</ArticleId><ArticleId IdType="pubmed">21920633</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J.D., Warren J.D., Reiman D., Uphill J., Beck J., Collinge J., Rossor M.N., Isaacs A.M., Mead S. A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes. J. Neurol. 2011;258:1494&#x2013;1496. doi: 10.1007/s00415-011-5966-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-5966-4</ArticleId><ArticleId IdType="pmc">PMC4606971</ArticleId><ArticleId IdType="pubmed">21387114</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V., Magri S., Bella E.D., Tannorella P., Bersano E., Soraru G., Gatti M., Ticozzi N., Taroni F., Lauria G., et al. Sorting Rare ALS Genetic Variants by Targeted Re-Sequencing Panel in Italian Patients: OPTN, VCP, and SQSTM1 Variants Account for 3% of Rare Genetic Forms. J. Clin. Med. 2020;9:412. doi: 10.3390/jcm9020412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020412</ArticleId><ArticleId IdType="pmc">PMC7073901</ArticleId><ArticleId IdType="pubmed">32028661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani L.L., Tesson C., Charles P., Cazeneuve C., Hahn V., Youssov K., Freeman L., Grabli D., Roze E., Noel S., et al. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach. JAMA Neurol. 2016;73:1105&#x2013;1114. doi: 10.1001/jamaneurol.2016.2215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.2215</ArticleId><ArticleId IdType="pubmed">27400454</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue M., Iida A., Hayashi S., Mori-Yoshimura M., Nagaoka A., Yoshimura S., Shiraishi H., Tsujino A., Takahashi Y., Nonaka I., et al. Two novel VCP missense variants identified in Japanese patients with multisystem proteinopathy. Hum. Genome Var. 2018;5:9. doi: 10.1038/s41439-018-0009-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41439-018-0009-7</ArticleId><ArticleId IdType="pmc">PMC5976715</ArticleId><ArticleId IdType="pubmed">29899994</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcao de Campos C., de Carvalho M. Distal myopathy and rapidly progressive dementia associated with a novel mutation in the VCP gene: Expanding inclusion body myopathy with early-onset Paget disease and frontotemporal dementia spectrum. J. Clin. Neurosci. 2019;64:8&#x2013;10. doi: 10.1016/j.jocn.2019.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2019.03.063</ArticleId><ArticleId IdType="pubmed">30955949</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Wu W., Xie Z., Gang Q., Yu M., Liu J., Wang Q., Lv H., Zhang W., Huang Y., et al. Novel and Recurrent Mutations in a Cohort of Chinese Patients With Young-Onset Amyotrophic Lateral Sclerosis. Front. Neurosci. 2019;13:1289. doi: 10.3389/fnins.2019.01289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01289</ArticleId><ArticleId IdType="pmc">PMC6908997</ArticleId><ArticleId IdType="pubmed">31866807</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahao A., Abath Neto O., Kok F., Zanoteli E., Santos B., Pinto W.B., Barsottini O.G., Oliveira A.S., Pedroso J.L. One family, one gene and three phenotypes: A novel VCP (valosin-containing protein) mutation associated with myopathy with rimmed vacuoles, amyotrophic lateral sclerosis and frontotemporal dementia. J. Neurol. Sci. 2016;368:352&#x2013;358. doi: 10.1016/j.jns.2016.07.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.07.048</ArticleId><ArticleId IdType="pubmed">27538664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbers C.U., Clemen C.S., Kesper K., Boddrich A., Hofmann A., Kamarainen O., Tolksdorf K., Stumpf M., Reichelt J., Roth U., et al. Pathological consequences of VCP mutations on human striated muscle. Brain. 2007;130:381&#x2013;393. doi: 10.1093/brain/awl238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl238</ArticleId><ArticleId IdType="pubmed">16984901</ArticleId></ArticleIdList></Reference><Reference><Citation>Neveling K., Feenstra I., Gilissen C., Hoefsloot L.H., Kamsteeg E.J., Mensenkamp A.R., Rodenburg R.J., Yntema H.G., Spruijt L., Vermeer S., et al. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum. Mutat. 2013;34:1721&#x2013;1726. doi: 10.1002/humu.22450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22450</ArticleId><ArticleId IdType="pubmed">24123792</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp M.J., Mawuenyega K.G., Patterson B.W., Reddy N.C., Chott R., Self W.K., Weihl C.C., Jockel-Balsarotti J., Varadhachary A.S., Bucelli R.C., et al. In vivo kinetic approach reveals slow SOD1 turnover in the CNS. J. Clin. Investig. 2015;125:2772&#x2013;2780. doi: 10.1172/JCI80705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI80705</ArticleId><ArticleId IdType="pmc">PMC4563686</ArticleId><ArticleId IdType="pubmed">26075819</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaleem M., Zhao A., Hamshere M., Myers A.J. Identification of a novel valosin-containing protein polymorphism in late-onset Alzheimer&#x2019;s disease. Neurodegener. Dis. 2007;4:376&#x2013;381. doi: 10.1159/000105158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000105158</ArticleId><ArticleId IdType="pubmed">17622780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J.M., Ke Y.H., Yue H., Liu Y.J., Zhang Z., Zhang H., Hu W.W., Wang C., He J.W., Hu Y.Q., et al. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family. Bone. 2013;52:9&#x2013;16. doi: 10.1016/j.bone.2012.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2012.09.012</ArticleId><ArticleId IdType="pubmed">23000505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando T., Nakamura R., Kuru S., Yokoi D., Atsuta N., Koike H., Suzuki M., Hara K., Iguchi Y., Harada Y., et al. The wide-ranging clinical and genetic features in Japanese families with valosin-containing protein proteinopathy. Neurobiol. Aging. 2020;100:120.e1&#x2013;120.e6. doi: 10.1016/j.neurobiolaging.2020.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.10.028</ArticleId><ArticleId IdType="pubmed">33339634</ArticleId></ArticleIdList></Reference><Reference><Citation>Saracino D., Clot F., Camuzat A., Anquetil V., Hannequin D., Guyant-Marechal L., Didic M., Guillot-Noel L., Rinaldi D., Latouche M., et al. Novel VCP mutations expand the mutational spectrum of frontotemporal dementia. Neurobiol. Aging. 2018;72:187.e11&#x2013;187.e14. doi: 10.1016/j.neurobiolaging.2018.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.037</ArticleId><ArticleId IdType="pubmed">30005904</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M., van Blitterswijk M.M., Vlam L., Rowicka P.A., van Vught P.W., Groen E.J., Spliet W.G., Engelen-Lee J., Schelhaas H.J., de Visser M., et al. VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2012;33:837.e7&#x2013;837.e13. doi: 10.1016/j.neurobiolaging.2011.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.006</ArticleId><ArticleId IdType="pubmed">22078486</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland-Freitas R., Graham J., Davis M., Geevasinga N., Vucic S., Ng K. Late onset distal myopathy of the upper limbs due to p.Ile151Val mutation in VCP. Muscle Nerve. 2016;54:165&#x2013;166. doi: 10.1002/mus.25073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25073</ArticleId><ArticleId IdType="pubmed">26853221</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ridder W., Azmi A., Clemen C.S., Eichinger L., Hofmann A., Schroder R., Johnson K., Topf A., Straub V., De Jonghe P., et al. Multisystem proteinopathy due to a homozygous p.Arg159His VCP mutation: A tale of the unexpected. Neurology. 2019;94:e785&#x2013;e796. doi: 10.1212/WNL.0000000000008763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008763</ArticleId><ArticleId IdType="pubmed">31848255</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara S., Shimizu T., Komori T., Mori-Yoshimura M., Minami N., Hayashi Y.K. Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein gene. Neuromuscul. Disord. 2016;26:436&#x2013;440. doi: 10.1016/j.nmd.2016.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2016.05.001</ArticleId><ArticleId IdType="pubmed">27209344</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., Liu S., Xiang L., Wang Y., Liu M., Liu S., Han T., Zhou Y., Wang J., Cai L., et al. Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population. J. Hum. Genet. 2016;61:1003&#x2013;1008. doi: 10.1038/jhg.2016.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jhg.2016.92</ArticleId><ArticleId IdType="pubmed">27439681</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Tahan S., Al-Obeidi E., Yoshioka H., Lakatos A., Weiss L., Grafe M., Palmio J., Wicklund M., Harati Y., Omizo M., et al. Novel valosin-containing protein mutations associated with multisystem proteinopathy. Neuromuscul. Disord. 2018;28:491&#x2013;501. doi: 10.1016/j.nmd.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2018.04.007</ArticleId><ArticleId IdType="pubmed">29754758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucente G., Almendrote M., Ramos-Fransi A., Martinez-Pineiro A., Camano P., Ballester-Lopez A., Lucia A., Carrato C., Nogales-Gadea G., Coll-Canti J. A novel mutation in the valosin-containing-protein gene found in a Spanish family. J. Neurol. Sci. 2018;391:112&#x2013;113. doi: 10.1016/j.jns.2018.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2018.06.010</ArticleId><ArticleId IdType="pubmed">30103957</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmio J., Sandell S., Suominen T., Penttila S., Raheem O., Hackman P., Huovinen S., Haapasalo H., Udd B. Distinct distal myopathy phenotype caused by VCP gene mutation in a Finnish family. Neuromuscul. Disord. 2011;21:551&#x2013;555. doi: 10.1016/j.nmd.2011.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2011.05.008</ArticleId><ArticleId IdType="pubmed">21684747</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Desaro P., Johnston A., Ross O.A., Wszolek Z.K., Ertekin-Taner N., Graff-Radford N.R., Rademakers R., Boylan K. Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS. Neurology. 2011;77:1102&#x2013;1103. doi: 10.1212/WNL.0b013e31822e563c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31822e563c</ArticleId><ArticleId IdType="pmc">PMC3174069</ArticleId><ArticleId IdType="pubmed">21880997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos E.M., Dokuru D.R., Van Berlo V., Wojta K., Wang Q., Huang A.Y., Deverasetty S., Qin Y., van Blitterswijk M., Jackson J., et al. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 2020;16:118&#x2013;130. doi: 10.1002/alz.12011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12011</ArticleId><ArticleId IdType="pmc">PMC7199807</ArticleId><ArticleId IdType="pubmed">31914217</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Perez P., Cirulli E.T., Drory V.E., Dabby R., Nisipeanu P., Carasso R.L., Sadeh M., Fox A., Festoff B.W., Sapp P.C., et al. Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology. 2012;79:2201&#x2013;2208. doi: 10.1212/WNL.0b013e318275963b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318275963b</ArticleId><ArticleId IdType="pmc">PMC3570818</ArticleId><ArticleId IdType="pubmed">23152587</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojkovic T., Hammouda el H., Richard P., Lopez de Munain A., Ruiz-Martinez J., Camano P., Laforet P., Penisson-Besnier I., Ferrer X., Lacour A., et al. Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget&#x2019;s disease of bone and frontotemporal dementia. Neuromuscul. Disord. 2009;19:316&#x2013;323. doi: 10.1016/j.nmd.2009.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2009.02.012</ArticleId><ArticleId IdType="pubmed">19364651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar K.R., Needham M., Mina K., Davis M., Brewer J., Staples C., Ng K., Sue C.M., Mastaglia F.L. Two Australian families with inclusion-body myopathy, Paget&#x2019;s disease of bone and frontotemporal dementia: Novel clinical and genetic findings. Neuromuscul. Disord. 2010;20:330&#x2013;334. doi: 10.1016/j.nmd.2010.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2010.03.002</ArticleId><ArticleId IdType="pubmed">20335036</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu J., Iwasa K., Yanase D., Yamada M. Inclusion body myopathy with Paget disease of the bone and frontotemporal dementia associated with a novel G156S mutation in the VCP gene. Muscle Nerve. 2013 doi: 10.1002/mus.23960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23960</ArticleId><ArticleId IdType="pubmed">23868359</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellerin D., Ellezam B., Korathanakhun P., Renaud M., Dicaire M.J., Pilote L., Levy J.P., Karamchandani J., Ducharme S., Massie R., et al. Multi-system proteinopathy associated with a VCP G156S mutation in a French Canadian family. Can. J. Neurol. Sci. 2020;47:412&#x2013;415. doi: 10.1017/cjn.2020.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.25</ArticleId><ArticleId IdType="pubmed">32036797</ArticleId></ArticleIdList></Reference><Reference><Citation>Segawa M., Hoshi A., Naruse H., Kuroda M., Bujo H., Ugawa Y. A patient with familial amyotrophic lateral sclerosis associated with a new valosin-containing protein (VCP) gene mutation. Rinsho Shinkeigaku. 2015;55:914&#x2013;920. doi: 10.5692/clinicalneurol.cn-000765.</Citation><ArticleIdList><ArticleId IdType="doi">10.5692/clinicalneurol.cn-000765</ArticleId><ArticleId IdType="pubmed">26511028</ArticleId></ArticleIdList></Reference><Reference><Citation>Djamshidian A., Schaefer J., Haubenberger D., Stogmann E., Zimprich F., Auff E., Zimprich A. A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia. Muscle Nerve. 2009;39:389&#x2013;391. doi: 10.1002/mus.21225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21225</ArticleId><ArticleId IdType="pubmed">19208399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaki T., Ito H., Fukushima H., Inoue T., Kondo T., Ikemoto A., Asano T., Shodai A., Fujita T., Fukui S., et al. Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant. Acta Neuropathol. Commun. 2014;2:172. doi: 10.1186/s40478-014-0172-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0172-0</ArticleId><ArticleId IdType="pmc">PMC4297454</ArticleId><ArticleId IdType="pubmed">25492614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hang Wong T., Pottier C., Hondius D., Meeter L.H.H., van Rooij J.G.J., Melhem S., Brain Bank T.N., van Minkelen R., van Duijn C.M., Rozemuller A.J.M., et al. Three VCP Mutations in Patients with Frontotemporal Dementia. J. Alzheimers Dis. 2018;65:1139&#x2013;1146. doi: 10.3233/JAD-180301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180301</ArticleId><ArticleId IdType="pubmed">30103325</ArticleId></ArticleIdList></Reference><Reference><Citation>Haubenberger D., Bittner R.E., Rauch-Shorny S., Zimprich F., Mannhalter C., Wagner L., Mineva I., Vass K., Auff E., Zimprich A. Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology. 2005;65:1304&#x2013;1305. doi: 10.1212/01.wnl.0000180407.15369.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000180407.15369.92</ArticleId><ArticleId IdType="pubmed">16247064</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J., Pirici D., Van Langenhove T., Engelborghs S., Vandenberghe R., Hoffmann M., Pusswald G., Van den Broeck M., Peeters K., Mattheijssens M., et al. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology. 2009;73:626&#x2013;632. doi: 10.1212/WNL.0b013e3181b389d9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b389d9</ArticleId><ArticleId IdType="pubmed">19704082</ArticleId></ArticleIdList></Reference><Reference><Citation>Bersano A., Del Bo R., Lamperti C., Ghezzi S., Fagiolari G., Fortunato F., Ballabio E., Moggio M., Candelise L., Galimberti D., et al. Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol. Aging. 2009;30:752&#x2013;758. doi: 10.1016/j.neurobiolaging.2007.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.08.009</ArticleId><ArticleId IdType="pubmed">17889967</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan N., Le C., Shieh P., Mozaffar T., Khare M., Bronstein J., Kimonis V. Valosin-containing protein mutation and Parkinson&#x2019;s disease. Parkinsonism Relat. Disord. 2012;18:107&#x2013;109. doi: 10.1016/j.parkreldis.2011.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2011.07.006</ArticleId><ArticleId IdType="pubmed">21816654</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bot S.T., Schelhaas H.J., Kamsteeg E.J., van de Warrenburg B.P. Hereditary spastic paraplegia caused by a mutation in the VCP gene. Brain. 2012;135:e223. doi: 10.1093/brain/aws201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws201</ArticleId><ArticleId IdType="pubmed">22991237</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotan D., Ozozen Ayas Z., Tunca C., Gungen B.D., Akcimen F., Basak A.N. Phenotypic and genotypic features of patients diagnosed with ALS in the city of Sakarya, Turkey. Acta Neurol. Belg. 2020;120:1411&#x2013;1418. doi: 10.1007/s13760-020-01441-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-020-01441-z</ArticleId><ArticleId IdType="pubmed">32671691</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G.D., Thomasova D., Ramdeen S.K., Fulchiero E.C., Mehta S.G., Drachman D.A., Weihl C.C., Jamrozik Z., Kwiecinski H., Kaminska A., et al. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin. Genet. 2007;72:420&#x2013;426. doi: 10.1111/j.1399-0004.2007.00887.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2007.00887.x</ArticleId><ArticleId IdType="pubmed">17935506</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Bonaparte S., Hudson J., Barresi R., Polvikoski T., Williams T., Topf A., Harris E., Hilton-Jones D., Petty R., Willis T.A., et al. Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK. J. Neurol. Neurosurg. Psychiatry. 2015;87:680&#x2013;681. doi: 10.1136/jnnp-2015-310362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310362</ArticleId><ArticleId IdType="pmc">PMC4893144</ArticleId><ArticleId IdType="pubmed">26105173</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyer A.K., Kinter J., Hench J., Frank S., Fuhr P., Thomann S., Fischmann A., Kneifel S., Camano P., Lopez de Munain A., et al. Novel valosin containing protein mutation in a Swiss family with hereditary inclusion body myopathy and dementia. Neuromuscul. Disord. 2013;23:149&#x2013;154. doi: 10.1016/j.nmd.2012.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2012.09.009</ArticleId><ArticleId IdType="pubmed">23140793</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina S., Van Laar A.D., Murrell J.R., Hamilton R.L., Kofler J.K., Epperson F., Farlow M.R., Lopez O.L., Quinlan J., DeKosky S.T., et al. Phenotypic variability in three families with valosin-containing protein mutation. Eur. J. Neurol. 2013;20:251&#x2013;258. doi: 10.1111/j.1468-1331.2012.03831.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2012.03831.x</ArticleId><ArticleId IdType="pmc">PMC3734548</ArticleId><ArticleId IdType="pubmed">22900631</ArticleId></ArticleIdList></Reference><Reference><Citation>Levesque S., Auray-Blais C., Gravel E., Boutin M., Dempsey-Nunez L., Jacques P.E., Chenier S., Larue S., Rioux M.F., Al-Hertani W., et al. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing. Orphanet J. Rare Dis. 2016;11:8. doi: 10.1186/s13023-016-0390-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-016-0390-6</ArticleId><ArticleId IdType="pmc">PMC4727295</ArticleId><ArticleId IdType="pubmed">26809617</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y., Johnson J.O., Scholz S.W., Taylor J.P., Brunetti M., Calvo A., Mandrioli J., Benatar M., Mora G., Restagno G., et al. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2012;33:2231.e1&#x2013;2231.e6. doi: 10.1016/j.neurobiolaging.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.04.005</ArticleId><ArticleId IdType="pmc">PMC3391327</ArticleId><ArticleId IdType="pubmed">22572540</ArticleId></ArticleIdList></Reference><Reference><Citation>Liewluck T., Milone M., Mauermann M.L., Castro-Couch M., Cerhan J.H., Murthy N.S. A novel VCP mutation underlies scapuloperoneal muscular dystrophy and dropped head syndrome featuring lobulated fibers. Muscle Nerve. 2014;50:295&#x2013;299. doi: 10.1002/mus.24290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24290</ArticleId><ArticleId IdType="pubmed">24838343</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., Hayashi Y.K., Mitsuhashi S., Goto K., Kaneda D., Choi Y.C., Toyoda C., Hieda S., Kamiyama T., Sato H., et al. Characterization of the Asian myopathy patients with VCP mutations. Eur. J. Neurol. 2012;19:501&#x2013;509. doi: 10.1111/j.1468-1331.2011.03575.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03575.x</ArticleId><ArticleId IdType="pubmed">22040362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano M., Nakamura Y., Saigoh K., Sakamoto H., Ueno S., Isono C., Mitsui Y., Kusunoki S. VCP gene analyses in Japanese patients with sporadic amyotrophic lateral sclerosis identify a new mutation. Neurobiol. Aging. 2015;36:1604.e1&#x2013;1604.e6. doi: 10.1016/j.neurobiolaging.2014.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.012</ArticleId><ArticleId IdType="pubmed">25457024</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos C., Kirchner P., Bug M., Grum D., Koerver L., Schulze N., Poehler R., Dressler A., Fengler S., Arhzaouy K., et al. VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J. 2017;36:135&#x2013;150. doi: 10.15252/embj.201695148.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695148</ArticleId><ArticleId IdType="pmc">PMC5242375</ArticleId><ArticleId IdType="pubmed">27753622</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., McLaughlin R.L., Byrne S., Elamin M., Heverin M., Kenny E.M., Cormican P., Morris D.W., Donaghy C.G., Bradley D.G., et al. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J. Med. Genet. 2013;50:776&#x2013;783. doi: 10.1136/jmedgenet-2013-101795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2013-101795</ArticleId><ArticleId IdType="pmc">PMC3812897</ArticleId><ArticleId IdType="pubmed">23881933</ArticleId></ArticleIdList></Reference><Reference><Citation>Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y.H., Narzisi G., Leotta A., et al. De novo gene disruptions in children on the autistic spectrum. Neuron. 2012;74:285&#x2013;299. doi: 10.1016/j.neuron.2012.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.04.009</ArticleId><ArticleId IdType="pmc">PMC3619976</ArticleId><ArticleId IdType="pubmed">22542183</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse A., Bertoni M., Bienert S., Studer G., Tauriello G., Gumienny R., Heer F.T., de Beer T.A.P., Rempfer C., Bordoli L., et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296&#x2013;W303. doi: 10.1093/nar/gky427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky427</ArticleId><ArticleId IdType="pmc">PMC6030848</ArticleId><ArticleId IdType="pubmed">29788355</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrodinger L., DeLano W. PyMOL.  [(accessed on 24 April 2022)].  Available online:  http://www.pymol.org/pymol.</Citation></Reference><Reference><Citation>Pan M., Yu Y., Ai H., Zheng Q., Xie Y., Liu L., Zhao M. Mechanistic insight into substrate processing and allosteric inhibition of human p97. Nat. Struct. Mol. Biol. 2021;28:614&#x2013;625. doi: 10.1038/s41594-021-00617-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-021-00617-2</ArticleId><ArticleId IdType="pubmed">34262183</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano L., Deceglie S., d&#x2019;Adamo P., Valentino M.L., La Morgia C., Fracasso F., Roberti M., Cappellari M., Petrosillo G., Ciaravolo S., et al. Cigarette toxicity triggers Leber&#x2019;s hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways. Cell Death Dis. 2015;6:e2021. doi: 10.1038/cddis.2015.364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.364</ArticleId><ArticleId IdType="pmc">PMC4720897</ArticleId><ArticleId IdType="pubmed">26673666</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G., Cote H.C., Montaner J.S., Li C.C., Jitratkosol M., Mezei M.M. Ophthalmoplegia and ptosis: Mitochondrial toxicity in patients receiving HIV therapy. Neurology. 2009;73:71&#x2013;72. doi: 10.1212/WNL.0b013e3181aae814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181aae814</ArticleId><ArticleId IdType="pmc">PMC2830882</ArticleId><ArticleId IdType="pubmed">19564587</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G., Sirrs S., Wade N.K., Mezei M.M. Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can. J. Neurol. Sci. 2011;38:119&#x2013;123. doi: 10.1017/S031716710001115X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S031716710001115X</ArticleId><ArticleId IdType="pubmed">21156440</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E., Bashiardes S., Shapiro H., Rothschild D., Mor U., Dori-Bachash M., Kleimeyer C., Moresi C., Harnik Y., Zur M., et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S.G., Watts G.D., Adamson J.L., Hutton M., Umberger G., Xiong S., Ramdeen S., Lovell M.A., Kimonis V.E., Smith C.D. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD) Genet. Med. 2007;9:9&#x2013;13. doi: 10.1097/GIM.0b013e31802d830d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GIM.0b013e31802d830d</ArticleId><ArticleId IdType="pubmed">17224685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby A.E., Kimonis V., Kompoliti K. Ataxia and Parkinsonism in a Woman With a VCP Variant and Long-Normal Repeats in the SCA2 Allele. Neurol. Genet. 2021;7:e595. doi: 10.1212/NXG.0000000000000595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000595</ArticleId><ArticleId IdType="pmc">PMC8362347</ArticleId><ArticleId IdType="pubmed">34395867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers M.R., Kim J., Kim N.C. Eip74EF is a dominant modifier for ALS-FTD linked mutant VCP phenotypes in Drosophila, but not miR-34. Biorxiv. 2020 doi: 10.1101/2020.11.20.375360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.20.375360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaga C., Findlay A.R., Goyal N.A., Robinson S., Cauchi J., Hussain Y., Wang L.H., Kershen J.C., Beson B.A., Wallendorf M., et al. Clinical utility of anti-cytosolic 5&#x2019;-nucleotidase 1A antibody in idiopathic inflammatory myopathies. Ann. Clin. Transl. Neurol. 2021;8:571&#x2013;578. doi: 10.1002/acn3.51294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51294</ArticleId><ArticleId IdType="pmc">PMC7951108</ArticleId><ArticleId IdType="pubmed">33556224</ArticleId></ArticleIdList></Reference><Reference><Citation>Posey J.E., Harel T., Liu P., Rosenfeld J.A., James R.A., Coban Akdemir Z.H., Walkiewicz M., Bi W., Xiao R., Ding Y., et al. Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation. N. Engl. J. Med. 2017;376:21&#x2013;31. doi: 10.1056/NEJMoa1516767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1516767</ArticleId><ArticleId IdType="pmc">PMC5335876</ArticleId><ArticleId IdType="pubmed">27959697</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiar M.A., Yu E., Haj Salem I., Ross J.P., Mufti K., Akcimen F., Leveille E., Spiegelman D., Ruskey J.A., Asayesh F., et al. Evidence for Non-Mendelian Inheritance in Spastic Paraplegia 7. Mov. Disord. 2021;36:1664&#x2013;1675. doi: 10.1002/mds.28528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28528</ArticleId><ArticleId IdType="pubmed">33598982</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl C.C., Pestronk A., Kimonis V.E. Valosin-containing protein disease: Inclusion body myopathy with Paget&#x2019;s disease of the bone and fronto-temporal dementia. Neuromuscul. Disord. 2009;19:308&#x2013;315. doi: 10.1016/j.nmd.2009.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2009.01.009</ArticleId><ArticleId IdType="pmc">PMC2859037</ArticleId><ArticleId IdType="pubmed">19380227</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugiardini E., Morrow J.M., Shah S., Wood C.L., Lynch D.S., Pitmann A.M., Reilly M.M., Houlden H., Matthews E., Parton M., et al. The Diagnostic Value of MRI Pattern Recognition in Distal Myopathies. Front. Neurol. 2018;9:456. doi: 10.3389/fneur.2018.00456.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00456</ArticleId><ArticleId IdType="pmc">PMC6028608</ArticleId><ArticleId IdType="pubmed">29997562</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Manera J., Llauger J., Gallardo E., Illa I. Muscle MRI in muscular dystrophies. Acta Myol. 2015;34:95&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859076</ArticleId><ArticleId IdType="pubmed">27199536</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimas G.K., Paraskevas G.P., Zambelis T., Karagiaouris C., Bourbouli M., Bougea A., Walter M.C., Schumacher N.U., Krause S., Kapaki E. The multifaceted clinical presentation of VCP-proteinopathy in a Greek family. Acta Myol. 2017;36:203&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953233</ArticleId><ArticleId IdType="pubmed">29770363</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul Tuck S., Layfield R., Walker J., Mekkayil B., Francis R. Adult Paget&#x2019;s disease of bone: A review. Rheumatology. 2017;56:2050&#x2013;2059. doi: 10.1093/rheumatology/kew430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew430</ArticleId><ArticleId IdType="pubmed">28339664</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes D.A., Barclay C.L., Duff J., Furukawa Y., Lang A.E. Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: Confusing the picture? J. Neurol. Neurosurg. Psychiatry. 2002;72:801&#x2013;804. doi: 10.1136/jnnp.72.6.801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.72.6.801</ArticleId><ArticleId IdType="pmc">PMC1737930</ArticleId><ArticleId IdType="pubmed">12023430</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrison N.A., Brothers K.B., Goldenberg A.J., Lynch J.A. Genomic Contextualism: Shifting the Rhetoric of Genetic Exceptionalism. Am. J. Bioeth. 2019;19:51&#x2013;63. doi: 10.1080/15265161.2018.1544304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15265161.2018.1544304</ArticleId><ArticleId IdType="pmc">PMC6397766</ArticleId><ArticleId IdType="pubmed">30676903</ArticleId></ArticleIdList></Reference><Reference><Citation>Laberge A.M., Richer J., Ravitsky V. Toward Broader Genetic Contextualism: Genetic Testing Enters the Age of Evidence-Based Medicine. Am. J. Bioeth. 2019;19:77&#x2013;79. doi: 10.1080/15265161.2018.1544315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15265161.2018.1544315</ArticleId><ArticleId IdType="pubmed">31307361</ArticleId></ArticleIdList></Reference><Reference><Citation>Slade I., Riddell D., Turnbull C., Hanson H., Rahman N., programme M.C.G. Development of cancer genetic services in the UK: A national consultation. Genome Med. 2015;7:18. doi: 10.1186/s13073-015-0128-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-015-0128-4</ArticleId><ArticleId IdType="pmc">PMC4341881</ArticleId><ArticleId IdType="pubmed">25722743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S.A., Bradbury A., Henderson V., Hoskins K., Bednar E., Arun B.K. Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency. Am. Soc. Clin. Oncol. Educ. Book. 2019;39:e33&#x2013;e44. doi: 10.1200/EDBK_238937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/EDBK_238937</ArticleId><ArticleId IdType="pubmed">31099680</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen J., Cousens N., Barlow-Stewart K., O&#x2019;Shea R., Andrews L. Online BRCA1/2 screening in the Australian Jewish community: A qualitative study. J. Community Genet. 2020;11:291&#x2013;302. doi: 10.1007/s12687-019-00450-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12687-019-00450-7</ArticleId><ArticleId IdType="pmc">PMC7295878</ArticleId><ArticleId IdType="pubmed">31879826</ArticleId></ArticleIdList></Reference><Reference><Citation>Scuffham T.M., MacMillan J.C. Huntington disease: Who seeks presymptomatic genetic testing, why and what are the outcomes? J. Genet. Couns. 2014;23:754&#x2013;761. doi: 10.1007/s10897-013-9678-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10897-013-9678-z</ArticleId><ArticleId IdType="pubmed">24399092</ArticleId></ArticleIdList></Reference><Reference><Citation>Godino L., Turchetti D., Jackson L., Hennessy C., Skirton H. Impact of presymptomatic genetic testing on young adults: A systematic review. Eur. J. Hum. Genet. 2016;24:496&#x2013;503. doi: 10.1038/ejhg.2015.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2015.153</ArticleId><ArticleId IdType="pmc">PMC4929872</ArticleId><ArticleId IdType="pubmed">26173961</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilleras K.H., Kjoelaas S.H., Dramstad E., Feragen K.B., von der Lippe C. Psychological reactions to predictive genetic testing for Huntington&#x2019;s disease: A qualitative study. J. Genet. Couns. 2020;29:1093&#x2013;1105. doi: 10.1002/jgc4.1245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgc4.1245</ArticleId><ArticleId IdType="pubmed">32162754</ArticleId></ArticleIdList></Reference><Reference><Citation>Surampalli A., Khare M., Kubrussi G., Wencel M., Tanaja J., Donkervoort S., Osann K., Simon M., Wallace D., Smith C., et al. Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia. J. Genet. Couns. 2015;24:842&#x2013;850. doi: 10.1007/s10897-015-9819-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10897-015-9819-7</ArticleId><ArticleId IdType="pmc">PMC5565393</ArticleId><ArticleId IdType="pubmed">25716352</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement S., Gargiulo M., Feingold J., Durr A. Guidelines for presymptomatic testing for Huntington&#x2019;s disease: Past, present and future in France. Rev. Neurol. 2015;171:572&#x2013;580. doi: 10.1016/j.neurol.2015.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2015.02.016</ArticleId><ArticleId IdType="pubmed">26002494</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalpe G., Pinkesz M., Oliviero E., Tolymbek M., Joly Y. Genetic discrimination views in online discussion forums: Perspectives from Canadian forumites. J. Genet. Couns. 2021;30:1613&#x2013;1628. doi: 10.1002/jgc4.1427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgc4.1427</ArticleId><ArticleId IdType="pubmed">33871129</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnett-Hartman A.N., Blum-Barnett E., Carroll N.M., Madrid S.D., Jonas C., Janes K., Alvarado M., Bedoy R., Paolino V., Aziz N., et al. Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse Groups. Public Health Genomics. 2020;23:59&#x2013;68. doi: 10.1159/000507056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000507056</ArticleId><ArticleId IdType="pubmed">32289795</ArticleId></ArticleIdList></Reference><Reference><Citation>Joly Y., Dalpe G., Dupras C., Beviere-Boyer B., de Paor A., Dove E.S., Granados Moreno P., Ho C.W.L., Ho C.H., K O.C., et al. Establishing the International Genetic Discrimination Observatory. Nat. Genet. 2020;52:466&#x2013;468. doi: 10.1038/s41588-020-0606-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-0606-5</ArticleId><ArticleId IdType="pubmed">32203466</ArticleId></ArticleIdList></Reference><Reference><Citation>de Paor A. Genetic Discrimination: A Case for a European Legislative Response? Eur. J. Health Law. 2017;24:135&#x2013;159. doi: 10.1163/15718093-12453366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1163/15718093-12453366</ArticleId><ArticleId IdType="pubmed">29210258</ArticleId></ArticleIdList></Reference><Reference><Citation>Clifton J.M., VanBeuge S.S., Mladenka C., Wosnik K.K. The Genetic Information Nondiscrimination Act 2008: What clinicians should understand. J. Am. Acad. Nurse Pract. 2010;22:246&#x2013;249. doi: 10.1111/j.1745-7599.2010.00504.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7599.2010.00504.x</ArticleId><ArticleId IdType="pubmed">20500738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>